GRPR and prostate neoplasm: Bandari et al. (2014) developed 64Cu-radiolabeled DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7–14)NH2, which is the first example of a dual GRPR/PSMA-targeting radioligand for the molecular imaging of prostate tumors.